:{olr Io

BIO SYSTEM LTD.

ncg. Omce: Office No. U/8,

{th

Floor, Sandesh Commercial Complex, Old Madhuram Cinema, Mirzapur, AHM EDABAD - 380001
Email : boslonsystem@yahoo.com Web :www.bostonbiosyslemlld.com

Ol

:. L3ltr0cJ 1sgsPtco 25476

30-o5-2016
To,

The Dept. of Corporate Services

The Stock Exchange, Mumbai
P. J. Towers 25th Floor
Dalal Street. Mumbai-4OO 001

Sub: AUDITED RESULTS ALONGWITH UNMODIFIED

OPINION REPORT AND LIMITED REVIEW REPORT OF
STATUTORY AUDITORS UNDER REGULATION 33 OF
SEBr(LODR),2O15 FOR QUARTER ENDED ON 31-032016 AND YEAR TO DATE AUDITED RESULTS FOR THE
FIN. YEAR 2OL5.2O16
Dear Madam/Sir

In compliance of above stated Regulation, we are submitting herewith the

above stated reports of the company for following quarter :-

31-O3-2016
Please take on record the same.
Yours Faithfully,
For BOSTON BIO SYSTEMS LIMITED
(Formerly lmown as LASER EYE CARE LTD.)

DrN -.06493647

Encl: As Stated

Annexure I to Clause 41
BOSTON BIO SYSTEMS LIMITED
office No. 17lB.4th Floor, sandesh commercia, complex, old Madhuram cinema, Mirzapur, Ahmebad'380001

Formattor submitting the quarterly financial results by companies other than banks

(Rs. ln Lakhs)

Year to Date
flgures for
figures for
current Period previous Period
ended (12
ended ('12
months ended) months ended)
Year to Date

months ended
Particulars

to3t2015

lnCrease/decrease in stock in
trade and work in Progress
b. Consumption of law materials
c. Purchase of traded goods
d. Employees cost
e. Depreciation
f. Other expenditure
g. Total
(Any item exceeding 10% of the
totalexpenditure to be shown

t31ro3t2015\

31/03/2015)

Audited

Unaudited

Audited

Audited

Audited

,udited

12.45

71.85

3.00

149.62

5.73

5.73

0.00

0.00

013

0.40

0.00

0.00

0.00

0.00

0.00

0.00

0.00
69.63
0.54

0.00
6.15

0.1'1

0.00
1.50

0.00
144.76
1.82
0.06
2.94

2. Exoenditure

Previous
accounting
year ended

t31t 1212015)

31/03/2016
1. (a) Net Sales/lncome from
Operations
/h\ othcr Oneratino lncome

Corresponding
Previous 3 month qtr- ended in the
ended
previous year

'11.83

4
-0.27
0.58
12.88
0.7

0.71

1.23

'149.58

71 .51

3'Profit from Ooerations before

0.00
0.00
0.00
2.01
0.06
3.6s
512 |

0.00

0.01

0.00
0.00
2.01

0.06
3.65
s tz

-0.43

o47

-4.96

0.04

0.01

0.0

0.00

0.00

0.00

0.0

-0.43

0.47

-4.96

0.04

0.q1

0.01

0.00

0.00

0.00

TJiofit

-0.43

0.47

-4.S6

0.04

0.01

0.01

A-ffi

0.00

0.00

0.00

0.00

0.00

0.00

-0.43

a.47

-4.96

0.04

0.01

0.01

000

U,UU

0.00

0.0(

0.00

-0.43

0.47

-4.96

0.0,

0.01

-0.04

0.00

0.00

0.00

0.00

0.00

-0.43

0.47

-4.96

0.0'l

-0.04

Other lncome. lnterest and

E.,^^.ri^..1 lr6mc /,1-,\

Profit before lnterest and

Exceptional ltems (3+4)
after lnterest but before
Exceotional ltems (5-6)
ntional items
9. Profit (+)/ Loss C) from
Ordinary Activities before tax
(7+8)
10. Tax expense
11. Net Profit (+)/ Loss (-) from
ordinary Activities after tax (9-10)
12. Extraoldinary ltem (net of tax
'13. Nat Proiit(+)/

Lossc) for the

period (1'1-12)
14. Paid-up equiiy share capital
(Face Value of the ShaIe shall be
indicated)
15. Reserve excluding
Revaluation Reserves as Per
balance sheet of Previous

2n'0

lo,
0.04
)0

7.

00

2lJ1)

Rs. '101

Rs. 10/-

Rs. 10/-

Rs. '10/-

Rs. 101

Rs. 1 0/-

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

000

0.00

0.00

0.00

0.00

6,843,250.00

6,843,250.00
97.73

ti,64J,Z5U.UU

6,843,250.00

97.73

97.73

6,843,250.00
97.73

6,843,250.00
97.73

iE-Elminaq Per Share {EPS

a) Basic and diluted EPS before

Extraordinary items for the

period, for the Yeat to date and
for the previous Year (not to be
c) Baaic and diluted EPS after

Extraordinary items for the

period, fol the year to date and
for the previous Year (not to be

00

'l7. Public Shareholding

- No. of shares
- Percentaqe of shareholding

97.73

Annexure lto Clause 41

BOSTON BIO SYSTEMS LIMITED
Mirzapur, Ahmebad-380001
office No. t7l8, 4th Floor, sandesh commercial complex, old Madhuram cinema,
banks
Format for submitting the quarterly financial results by companies otherthan
Year to Date
figures for
curaent Period previous Period
ended ('12
ended (12
months ended) months ended)
Year to Date

figures tor

18. Promoters and

Profioter

Pledged/Encumbercd
Number of shares
ol shares (as a oA
of the total shareholding of
and promoter gtouP)

of sharcs (as

aoh

of

total sharc caPital of the

company)
b) Non-encumbeted

Number of Shares
Percentage of shares (as ao/5
the total shareholding of
and prcmolet grouP)

the total sharc caPital

158,950.00

158,950.00

158,9s0.00

158,950.00

158,950.00

1s8,950.00

100.00

100.00

100.00

100.00

100.00

100.00

oflhe

ivotesl

1.
2.
S.

by Board of Directors at its

The above results have been reviewed by Audit Committee and approved
meeting held on 30.05.2016
issued by the lnstitute of Chartered
The Co-mpany's report is based on the Accounting Standards
Accountants of lndia
one complaints from the investors
During the auarter ended 31.03-2016 the company has received
with the Company at the end of the Quarter'
and rJsolved properly and now no complaint liing unresolved
For & Behalf of Boston Bio Systems Limited

sd/KUSHAL MTHORE
Dlrector

NAIIAR V & COMPANY

Chartered Accountants.

ANNEXURE

VII

To,
Ir4ls BOSTON BIO SYSTEMS

LTD.,

AHMEDABAD

we
a.rdited the quarterly financial results of M/s BosroN BIo sysrEMS
LIMITED for the quarter ended
-have
on.3l./03/2016
and the year to date results for the period 0l/04/2015 to 31/03/2016 attached
herewirh, being
submitted-by the company pursuant to the requirement of Regulation :g of trre
ieslilonnl.,z0l5
These
quarterly financial results as well as the year to date financial ,"rrl-t, hur.
b""n p."pu."d * ihe basis ofthe interim
financial statements, which are the. responsibility of the company', .unug.r.rt. bur responsibility
is to express
an opinion on these financial results based on our audit of such interirn-financial statements,
which have been
prepared in accordance with the recognition and measurement principles laid
down
in
Accounting
Standard for
Interim Financial Reporting (AS25/ Ind As34), prescribed, u/s li3 of -Co.Act,2013 read with
relevant rules issued
thereunder; or by the ICAI, as applicable and otlier accounting principles geneially
u"""pt"Jin Indiu.

We conducted our audit in accordance with the auditing standards generally accepted in India. Those
standards
require that we plan and perform the audit to obtain reasonable ursriurce about wiether the financial
results are
free-of material misstatement(s). An audit includes examining, on a test basis, evidence supporting
the amounts
disclosed as financial results. An audit also includes u"."..ing the accounting principles
used and significant
estimates made by management. We believe that our audit proviJes a reasonableijsir
f"l"r.

"piri"",

In our opinion

and to the best of our information and according to the explanations given to us these quarterly
financial results as well as the ye4ar to date results :

(i)

Are presented in accordance with the requiremenr olRegulation 33 of SEBI (LODR),2015

in rhis regard;
and

(ii)

Give a true and fair view of the net profit /loss and other financial information for the quarter ended on
31.03.2016 as well as the year to date results for the period from 0l -04-2015 to 3l/0312016.

V& Co.,
Chartered Accountants,
For Nahar

(VISHALNAHAR)
PARTNER
F.R.N.010443C
MEM. NO. 400217

PLACE:INDORE
DATED :30-05-2016

NAHARV& COMPANY
Chartered Accountants,

To,
M/s Boston Bio Systems Ltd_,
Ahmedabad(Guj.)

we have reviewed the accompanying statement of unaudited financial results of ItTs

Boston Bio Systems Ltd. For
the qtr' Ended 31st Mar,2016 except for the disclosures regarding 'Public Shareholding'
and ,promoter and
Promoter Group Shareholding' which have been traced from disclosures made
by the management and have
not

been audited by us. This statement is the responsibility of the Company,s

IrA*ug"-""t'*d h-as been approved by
the Board of directors/ Audit committee. our responsibility is to issue a report
oi tir"." fir*"lal statements based
on our review.

we conducted our revierv in accordance with the Standard on Review Engagement (SRE)
2400, engagements to
Revieu' Financial Statements issued by the Institute of Chartered Accountaits-of
Inaia. rus Standard-reluires thai
r"e plan and perform the review to.obtain moderate assurance as
to whether the financial statements are free of
material misstatement. A review is limited primarily to inquiries of company p"..o,r*t-una
analltical procedures
appiied to financial data and thus providei less assurance than an audit.
w;
perfbrmed an audit and
accordingly. we do not express an audit opinion.

h;;;;;,

Based on our revier'v conducted as above, nothing has come

to our attention that causes us to believe that the
accompanying statement of unaudited. financial results prepared in
accordance with applicable u..ountlng
s.tandards
other recognized ac^cgunling.practices and poh"ies has not disclosed
.and
the intbrmation required to be
disclosed in terms of clause 4l of the Lisiing Agreemeni i,cluding
the mar-er in *rrilr.. l, is to be disclosed, or
ihat it corrtains any mater.ial misstatement.

For Nahar V&Co.,

C

hartered Accountants,

( VISHALNAHAR)
P,.\RTNER
F.R.N. 010443C

i{EM. NO.400217
PLACE: INDORE
DATED :30-05-2016